<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Sanofi-Aventis | Company News & Executive Profiles | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/sanofi-aventis.html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Sanofi-Aventis]]></description>
	<s:counts start="0" returned="10" found="137" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Sanofi vet group plots $70M China expansion]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/sanofi-vet-group-plots-70m/15523/]]></link>
		<description><![CDATA[Sanofi-Aventis animal health group Merial broke ground for a $70 million expansion of a poultry-vaccines plant in the Nanchang development zone in China. Release More information about formatting options]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Tue, 13 Oct 2009 09:05:31 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/expansion.html"><![CDATA[Expansion]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/animal+health.html"><![CDATA[animal health]]></category>
	</item>
	<item>
		<title><![CDATA[Supreme Court Denies Aventis' Cert Petition in Lovenox Case]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F133850-supreme-court-denies-aventis-cert-petition-in-lovenox-case%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Aaron F. Barkoff submits:  Aventis Pharma v. Amphastar and Teva, S. Ct. Appeal No. 08-937 (2009)   The Supreme Court on Monday denied Aventis Pharma's SNY cert petition in a long-running dispute with generic biopharmaceutical manufacturer Amphastar.  In its petition, Aventis had asked the Court to review...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 28 Apr 2009 11:17:39 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/aaron+f.+barkoff.html"><![CDATA[Aaron F. Barkoff]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
	</item>
	<item>
		<title><![CDATA[Sanofi-Aventis Reaffirms Commitment to China Public Health with New Facility]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F132212-sanofi-aventis-reaffirms-commitment-to-china-public-health-with-new-facility%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  Sanofi-Aventis (NYSE: SNY) will invest 600 million RMB ($90 million) to expand its Beijing manufacturing facility to produce the company&#8217;s insulin drug, Lantus. Lantus is a pre-filled injection, delivered via the SoloSTAR pen device, which provides once-daily insulin to people with type 1 and type 2...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 21 Apr 2009 11:43:49 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
	</item>
	<item>
		<title><![CDATA[14 Drug Companies Cited for Misleading Google Ads]]></title>
		<link><![CDATA[http://industry.bnet.com/advertising/10001524/14-drug-companies-cited-for-misleading-google-ads/]]></link>
		<description><![CDATA[The FDA cited 14 drug companies for misleading advertising in sponsored ads among Google search results.    Those cited: Biogen Idec, Sanofi Aventis, GlaxoSmithKline, Forest Laboratories, Cephalon, Bayer, Johnson & Johnson, Pfizer, Novartis , Genentech, Boehringer Ingelheim, Merck, Hoffman-LaRoche, and Eli Lilly.    The citations, sent...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Tue, 07 Apr 2009 12:44:01 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/google+inc..html"><![CDATA[Google Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/bayer+ag.html"><![CDATA[Bayer AG]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/advertisement.html"><![CDATA[Advertisement]]></category>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BAYR Y</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
		<category domain="tickers">BAYR Y,GOOG</category>
	</item>
	<item>
		<title><![CDATA[Why Is Biogen Idec on the Rise?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F130045-why-is-biogen-idec-on-the-rise%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Derek Lowe submits:  Biogen Idec BIIB has continued to fight off Carl Icahn, opposing his nominees to the company's board and setting up a fight at the annual meeting later this year.    But Tuesday morning as a correspondent has just pointed out to me the company's...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 07 Apr 2009 11:07:50 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/derek+lowe.html"><![CDATA[Derek Lowe]]></category>
		<category domain="http://resources.bnet.com/topic/biogen+idec+inc..html"><![CDATA[Biogen Idec Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
		<category domain="tickers">BIIB</category>
	</item>
	<item>
		<title><![CDATA[Sanofi Q4: No Nasty Surprises, But Viehbacher Is Focused on Sales Productivity Ratios]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000970/sanofi-q4-no-nasty-surprises-but-viehbacher-is-focused-on-sales-productivity-ratios/]]></link>
		<description><![CDATA[There were no nasty surprises in Sanofi-Aventis's Q4 results. Yesterday, BNET had suggested that CEO Chris Viehbacher's desire to cut $1.3 billion in operating costs would fall upon sales reps, whose jobs would be axed.    We also noted that, dollar for dollar (or euro for euro, in...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Wed, 11 Feb 2009 08:42:36 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/ceo.html"><![CDATA[CEO]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/workforce+management.html"><![CDATA[Workforce Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Zacks Bull & Bear of the Day Highlights: InterDigital, Overstock.com, Sanofi-Aventis, Bristol-Myers Squibb and Biogen Idec]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2009_Feb_3/ai_n31301563]]></link>
		<description><![CDATA[CHICAGO -- Zacks Equity Research picks InterDigital Inc. (Nasdaq: IDCC) as Bull of the Day and Overstock.com (Nasdaq: OSTK) as Bear of the Day. In addition, the analysts at Zacks Equity Research discuss the latest on Sanofi-Aventis (NYSE: SNY), Bristol-Myers Squibb (NYSE: BMY) and Biogen Idec (Nasdaq: BIIB).  Full...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 03 Feb 2009 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biogen+idec+inc..html"><![CDATA[Biogen Idec Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/interdigital+inc..html"><![CDATA[InterDigital Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/new+york+stock+exchange.html"><![CDATA[New York Stock Exchange]]></category>
		<category domain="http://resources.bnet.com/topic/overstock.com+inc..html"><![CDATA[Overstock.com Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OSTK</category>
		<category domain="tickers">BIIB,BMY,NDAQ,OSTK</category>
	</item>
	<item>
		<title><![CDATA[Sanofi-Aventis HQ Sells for $230 Million]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000493/sanofi-aventis-hq-sells-for-230-million/]]></link>
		<description><![CDATA[Sanofi-Aventis leases its North American headquarters in Bridgewater, N.J. Renting is fine for some, but a recent deal indicates that despite the declining real estate market, Sanofi may have been better off buying its 670,000-foot complex.    The Sanofi building, owned by SL Green Realty Corp. and Gramercy...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Thu, 11 Dec 2008 20:54:36 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis+hq.html"><![CDATA[Sanofi-Aventis HQ]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi.html"><![CDATA[Sanofi]]></category>
		<category domain="http://resources.bnet.com/topic/real+estate.html"><![CDATA[Real Estate]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Should Sanofi-Aventis Buy Bristol Myers-Squibb?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000341/should-sanofi-aventis-buy-bristol-myers-squibb/]]></link>
		<description><![CDATA[Bristol-Myers Squibb CEO James Cornelius said in a recent earnings call that due to its healthy cash position it may be on the prowl for biotech acquisitions. That's ironic because it is looking more like BMS itself could be the company to be acquired, possibly by Sanofi-Aventis.   ...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Mon, 27 Oct 2008 12:37:30 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/ceo.html"><![CDATA[CEO]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi.html"><![CDATA[Sanofi]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/ceo.html"><![CDATA[CEO]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi.html"><![CDATA[Sanofi]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Yangtze River Delta Developing Huge R&D Base for Drug Companies]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F94518-yangtze-river-delta-developing-huge-r-d-base-for-drug-companies%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  [Editor&#8217;s note: The following article originates from coverage of the BioBay Investor Forum 2008, presented by ChinaBio on August 27/28 in Suzhou. It was hosted by BioBay, the life science park in Suzhou. The article is reprinted with permission from Interfax China. Interfax China pharma news...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 09 Sep 2008 12:32:41 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/abbott+laboratories+inc..html"><![CDATA[Abbott Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/charles+river+laboratories+international+inc..html"><![CDATA[Charles River Laboratories International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/johnson+%2526+johnson.html"><![CDATA[Johnson & Johnson]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CRL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">ABT,AZN,CRL,LLY,GSK,JNJ,NVS,PFE</category>
	</item>
</channel>
</rss>
